Core Decompression for Osteonecrosis of the Femoral Head in Pediatric Hematologic Malignancy Survivors: A Systematic Review.
메타분석
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
환자: a history of hematologic malignancy who developed ONFH
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Level of Evidence: Level III, Diagnostic study. (Journal of Surgical Orthopaedic Advances 35(1):010-013, 2026).
Children treated for leukemia or lymphoma are predisposed to a higher incidence of osteonecrosis at a young age.
- 연구 설계 systematic review
APA
Krisanda EK, Morris CD, Levin AS (2026). Core Decompression for Osteonecrosis of the Femoral Head in Pediatric Hematologic Malignancy Survivors: A Systematic Review.. Journal of surgical orthopaedic advances, 35(1), 10-13.
MLA
Krisanda EK, et al.. "Core Decompression for Osteonecrosis of the Femoral Head in Pediatric Hematologic Malignancy Survivors: A Systematic Review.." Journal of surgical orthopaedic advances, vol. 35, no. 1, 2026, pp. 10-13.
PMID
41811254 ↗
Abstract 한글 요약
Children treated for leukemia or lymphoma are predisposed to a higher incidence of osteonecrosis at a young age. Core decompression (CD) is performed for treatment of osteonecrosis of the femoral head (ONFH) to delay or prevent subchondral collapse and subsequent total hip arthroplasty (THA). The goal of the present systematic review was to determine outcomes of CD in pediatric patients with a history of hematologic malignancy who developed ONFH. Of 4,424 studies screened by title, abstract, and full text, 4 retrospective studies were included. Of 253 hips with ONFH, CD was performed in 78 (30.8%). Conversion to THA occurred in 46.2% of patients an average of 20.3 months after CD. None of the studies reported a significant difference in risk of joint collapse following CD. There is limited evidence for or against the use of CD in the treatment of ONFH for pediatric patients with a history of hematologic malignancy. Level of Evidence: Level III, Diagnostic study. (Journal of Surgical Orthopaedic Advances 35(1):010-013, 2026).
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.